| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/29/2003 | US6599522 For therapy and prophylaxis of hyperlipidemia (hypertriglyceridemia) |
| 07/29/2003 | US6599519 Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/29/2003 | US6599513 For use in personal care and dermatological products |
| 07/29/2003 | US6599512 Electrolyte content w/o emulsions for treating irritated/sensitive skins |
| 07/29/2003 | US6599511 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6599449 X-ray crystallography reagent |
| 07/29/2003 | US6599284 Osmotic device having a preformed passageway that increases in size |
| 07/29/2003 | US6598603 Method for treating respiratory diseases |
| 07/29/2003 | US6598371 Capsules |
| 07/29/2003 | CA2272417C Adjuvant for transcutaneous immunization |
| 07/29/2003 | CA2269745C Improved treatment of migraine headache |
| 07/29/2003 | CA2269502C Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof |
| 07/29/2003 | CA2136404C Mucoadhesive, therapeutic or hygienic solid composition for application on oral or nasal mucosa |
| 07/29/2003 | CA2113914C Phospholipid derivative and liposome containing it |
| 07/29/2003 | CA2102530C Therapeutic agent |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/28/2003 | CA2398226A1 Increased-dosage nelfinavir tablet and method of making same |
| 07/24/2003 | WO2003060799A2 Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060076A2 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | WO2003059937A2 Synthetic ion channels |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059848A2 Hybrid immobilized catalytic system with controlled permeability |
| 07/24/2003 | WO2003059807A2 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | WO2003059542A1 Method for neutralizing or recycling carrier materials for film-like coatings |
| 07/24/2003 | WO2003059424A1 Methods and systems for operating an aerosol generator |
| 07/24/2003 | WO2003059417A1 Bicarbonate-based solutions for dialysis therapies |
| 07/24/2003 | WO2003059416A1 Production of a dialysis concentrate from a highly densified concentrate precursor and device for using on the site of dialysis |
| 07/24/2003 | WO2003059404A2 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 07/24/2003 | WO2003059391A2 Viscoelastics for ocular surgery |
| 07/24/2003 | WO2003059390A1 Oral mucoadhesive film |
| 07/24/2003 | WO2003059389A1 Medicinal compositions for improving oral absorption |
| 07/24/2003 | WO2003059388A1 Formulations of quinapril and related ace inhibitors |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059368A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | WO2003059358A1 25-hydroxy vitamin d3 compositions |
| 07/24/2003 | WO2003059349A1 Sedative non-benzodiazepine formulations |
| 07/24/2003 | WO2003059344A1 Suppositories containing indole derivative |
| 07/24/2003 | WO2003059338A1 Process for producing liquid preparation containing branched amino acids |
| 07/24/2003 | WO2003059337A1 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid |
| 07/24/2003 | WO2003059333A2 Stimulation of the immune system with polydextrose |
| 07/24/2003 | WO2003059332A2 Use of an anti-microtubule agent for the treatment of uveitis |
| 07/24/2003 | WO2003059331A2 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | WO2003059330A1 Stable pharmaceutical compositions comprising ace inhibitor(s) |
| 07/24/2003 | WO2003059329A2 Polytartrate composition |
| 07/24/2003 | WO2003059328A1 Formulations |
| 07/24/2003 | WO2003059327A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/24/2003 | WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 07/24/2003 | WO2003059325A1 Magnetic delivery compositions |
| 07/24/2003 | WO2003059324A1 Method of producing hollow, microporous particles which are intended, in particular, to be inhaled |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059322A1 Efficient nucleic acid encapsulation into medium sized liposomes |
| 07/24/2003 | WO2003059321A1 Use of oligomers and polymers for drug solublization, stabilization, and delivery |
| 07/24/2003 | WO2003059320A1 Composition and method for the treatment of anorectal disorders |
| 07/24/2003 | WO2003059319A1 Drug nanoparticles from template emulsions |
| 07/24/2003 | WO2003059318A2 Medicated tampon |
| 07/24/2003 | WO2003059317A2 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 07/24/2003 | WO2003059316A1 Medicinal aerosol formulations comprising ion pair complexes |
| 07/24/2003 | WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 07/24/2003 | WO2003059284A2 Composition and method for inhibiting hypersensitivity |
| 07/24/2003 | WO2003059280A2 Efficient liposomal encapsulation |
| 07/24/2003 | WO2003059279A2 Efficient liposomal encapsulation under mild conditions |
| 07/24/2003 | WO2003059274A2 Vitamin formulation for cardiovascular health |
| 07/24/2003 | WO2003059263A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | WO2003059250A2 Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide |
| 07/24/2003 | WO2003059221A1 Composition and method for inhibiting hypersensitivity |
| 07/24/2003 | WO2003059197A2 The use of sulfonated compounds as a barrier contraceptive |
| 07/24/2003 | WO2003059194A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 07/24/2003 | WO2003059193A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/24/2003 | WO2003059088A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | WO2003059082A1 Center-filled chewing gum containing calcium |
| 07/24/2003 | WO2003059072A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | WO2003059069A1 Methods for preserving ophthalmic solutions and preserved ophtalmic solutions |
| 07/24/2003 | WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium |
| 07/24/2003 | WO2003034998A3 Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility |
| 07/24/2003 | WO2003005839A3 Edibles containing edible optical elements and methods |
| 07/24/2003 | WO2003002091A3 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 07/24/2003 | WO2002100325A3 Polyvalent nanoparticles |
| 07/24/2003 | WO2002092028A3 Oral care compositions |
| 07/24/2003 | WO2002047665A3 Methods and compositions for encapsulating active agents |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002036100A9 Controlled release metformin compositions |
| 07/24/2003 | US20030140360 Transgenic mammals and reagents for improving long-term memory |
| 07/24/2003 | US20030139811 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 07/24/2003 | US20030139732 Osmotic agent imbibes liquid from a surrounding environment through a semipermeable body to cause the piston to move and in turn causing drug delivery |
| 07/24/2003 | US20030139731 Device for transcutaneous drug delivery and uses therefor |
| 07/24/2003 | US20030139727 Transdermal transport device with suction |
| 07/24/2003 | US20030139709 Tampon body manufactured at first manufacturing facility and dosage form coupled to body, dosage form includes therapeutic agent manufactured at second facility |
| 07/24/2003 | US20030139698 Medicated wrap |
| 07/24/2003 | US20030139582 Composition containing biologically active polypeptides suitable for the oral administration |
| 07/24/2003 | US20030139495 Aqueous solution of polymer and chitosan; drug delivery |
| 07/24/2003 | US20030139468 Antiarrhythmia agent |
| 07/24/2003 | US20030139461 Antidiabetic formulation and method |
| 07/24/2003 | US20030139444 Storage stability; mixture containing glycine hydrochloride |
| 07/24/2003 | US20030139437 Respiratory system disorders; dextromethorphan in anhydrous solvents |